Mutations, drugs drive cancer by blurring growth signals: Researchers control common cancer pathway in lab with pulses of light

Genetic mutations in a form of non-small cell lung cancer (NSCLC) may drive tumor formation by blurring cells' perception of key growth signals, according to a new laboratory study. The research could have important implications for understanding and ultimately targeting the defective mechanisms underlying many human cancers.



See posts by others with similar interest

You may be interested in

Tell others about your work


Scraps written yesterday

Your works only be popular when others learn about your work.

Terms . Privacy . Help . Newsroom . Contact Us

MachPrinciple © 2020